Suppr超能文献

原发性甲状腺淋巴瘤的发病情况和预后因素,以及化疗和手术后患者的预后模型构建:一项基于人群的研究。

Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study.

机构信息

Department of Pathology, Wannan Medical College, Wenchang West Road 22, Wuhu, Anhui, China.

Department of Health Inspection and Quarantine, Wannan Medical College, Wenchang West Road 22, Wuhu, Anhui, China.

出版信息

BMC Endocr Disord. 2021 Apr 13;21(1):68. doi: 10.1186/s12902-021-00732-7.

Abstract

BACKGROUND

Primary thyroid lymphoma (PTL) is a rare thyroid malignancy, there are few large sample studies on PTL and no standardized treatment regimen has been established due to the rarity. The aims of this study were to explore the incidence and prognostic factors of PTL and construct visual prognostic prediction models for post-chemotherapy and postoperative patients.

METHODS

The incidence of PTL in 1975-2017 was extracted from the US Surveillance, Epidemiology, and End Results (SEER) database, then assessed using joinpoint regression software. A total of 1616 eligible PTL patients diagnosed in 1998-2016 were brought into prognostic analysis. Multivariate Cox regression analyses were carried out to reveal independent prognostic elements for overall survival (OS) and cancer-specific survival (CSS).

RESULTS

PTL incidence showed a relatively steady increase in 1975-1994, which annual percent change (APC) was 4.0%, and steady decreasing in 1994-2017(APC - 2.4%). Age, marital status, lymphoma Ann Arbor stage, histological subtypes, surgery, chemotherapy, and radiation were significantly correlated to OS and CSS. Nomograms were constructed to predict OS and CSS in post-chemotherapy and postoperative PTL patients separately, and were verified to have good reliability.

CONCLUSIONS

The incidence of PTL increased and subsequently decreased. We revealed the prognostic implications and constructed reliable nomograms for post-chemotherapy and postoperative PTL patients.

摘要

背景

原发性甲状腺淋巴瘤(PTL)是一种罕见的甲状腺恶性肿瘤,由于其罕见性,对 PTL 的大型样本研究较少,尚未建立标准化的治疗方案。本研究旨在探讨 PTL 的发病率和预后因素,并为化疗后和手术后患者构建可视化预后预测模型。

方法

从美国监测、流行病学和最终结果(SEER)数据库中提取 1975-2017 年 PTL 的发病率,然后使用 joinpoint 回归软件进行评估。对 1998-2016 年诊断的 1616 例合格 PTL 患者进行预后分析。采用多变量 Cox 回归分析揭示总生存(OS)和癌症特异性生存(CSS)的独立预后因素。

结果

PTL 发病率在 1975-1994 年呈相对稳定增长,年变化百分比(APC)为 4.0%,1994-2017 年呈稳定下降(APC-2.4%)。年龄、婚姻状况、淋巴瘤 Ann Arbor 分期、组织学亚型、手术、化疗和放疗与 OS 和 CSS 显著相关。分别为化疗后和手术后 PTL 患者构建了预测 OS 和 CSS 的列线图,并验证了其具有良好的可靠性。

结论

PTL 的发病率增加,随后减少。我们揭示了预后意义,并为化疗后和手术后 PTL 患者构建了可靠的列线图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/297a/8045392/0de1a6bc2f07/12902_2021_732_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验